Elanco Animal Health Incorporated (ELAN) Q3 2022 Earnings Call Transcript

SA Transcripts
153.12K Followers

Q3: 2022-11-08 Earnings Summary

EPS of $0.20 beats by $0.04
 | Revenue of $1.03B (-9.11% Y/Y) misses by $673.88K

Elanco Animal Health Incorporated (NYSE:ELAN) Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET

Company Participants

Katy Grissom - Head of Investor Relations
Jeff Simmons - President & Chief Executive Officer
Ellen de Brabander - Executive Vice President of Innovation & Regulatory Affairs
Todd Young - Chief Financial Officer

Conference Call Participants

Mike Ryskin - Bank of America
Erin Wright - Morgan Stanley
Umer Raffat - Evercore ISI
Nathan Rich - Goldman Sachs
Balaji Prasad - Barclays
Jonathan Block - Stifel
Brandon Vazquez - William Blair
Michael Parolari - Raymond James

Operator

Good morning. My name is Rob, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Elanco Animal Health's Third Quarter 2022 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.

Katy Grissom, Head of Investor Relations, you may begin your conference.

Katy Grissom

Good morning. Thank you for joining us for Elanco Animal Health's third quarter 2022 earnings call. I'm Katy Grissom, Head of Investor Relations. Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; Ellen de Brabander, our Executive Vice President of Innovation and Regulatory Affairs; and Scott Purucker, from Investor Relations.

The slides referenced during this call are available on the Investor Relations section of elanco.com. Today's discussion will include forward-looking statements. These statements are based on our current assumptions and expectations and are subject to risks and uncertainties that could cause actual results to differ materially from our forecast. For more information, see the risk factors discussed in today's earnings press release, as well as our latest Form 10-K and 10-Q filed with the SEC. We do not undertake

Recommended For You

About ELAN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ELAN